DENVER — In addition to the established gastrointestinal side effects common with the highly effective anti-obesity drugs, there is growing discussion around their potential to contribute to the loss ...

A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that ...

Using a groundbreaking muscle loss treatment with GLP-1 drugs like Mounjaro and Wegovy can counteract a major side effect of losing weight ...

A protein called B cell lymphoma 6 (BCL6) could be key to maintaining healthy muscle mass, and potentially could be used to combat muscle wasting conditions in humans, a study in mice suggests.

If you don’t use it, you lose it. That’s common wisdom, backed up by science, about what happens to aging muscles. And if your goal is to lose weight – whether you have obesity or a few pounds to drop ...

Patients receiving apitegromab with tirzepatide over 24 weeks showed a 54.9% preservation of lean mass (+4.2 lbs of lean mass) versus tirzepatide alone (p=0.001) Patients receiving apitegromab with ...

US WITH THE ANSWER TODAY. WELL, BEN, THE DOCTOR I SPOKE TO FROM TUFTS MEDICAL CENTER SAYS IT’S BEEN FRUSTRATING NAVIGATING THESE INSURANCE CHANGES. BUT HEALTH PLAN EXPERTS SAY IT’S JUST UNSUSTAINABLE ...

It is common after the age of 30 for people to start gaining weight, depending on metabolism, lifestyle and hormones. Extreme dieting and repeated weight loss attempts can upset the body’s natural ...

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the publication of a study demonstrating an average lean mass gain of 5 ...

PROPANE RELATED. NOW TO FIVE ON YOUR HEALTH. A NEW STUDY LED BY MASS IONEER FOUND A POTENTIAL LINK BETWEEN POPULAR DRUGS THAT HELP WITH WEIGHT LOSS AND A RARE FORM OF BLINDNESS. SO THE STUDY WAS ...